Blood Group Specificity Research Articles

Examination of the relationship between ABO/Rh blood groups and dietary compliance in children with coeliac disease: A single-centre experience.

Coeliac disease (CD) is an autoimmune enteropathy that develops upon ingestion of food containing gluten. The established link between ABO blood groups and numerous infectious and non-infectious illnesses prompted this investigation into blood group distribution and its relationship with dietary compliance among children diagnosed with CD. In this retrospective study, patients with CD who were followed for ≥1 year at the paediatric gastroenterology outpatient clinic of our hospital were evaluated. History, physical examination and coeliac serology results were reviewed for each patient. Patients were divided into two groups based on self-reported compliance to a gluten-free diet: diet-adherent and non-diet-adherent. Patient and control groups were examined in terms of ABO blood groups. A total of 177 patients with CD were included in the study. A control group of 211 age- and sex-matched children without any chronic disease who had undergone blood group testing for various reasons was included for comparison. A total of 65% (n = 115) of the patients were girls, and 35% (n = 62) were boys. No significant relationship was found between CD diagnosis and ABO blood groups among patients (P = 0.559). Furthermore, the dietary compliance status of the patients was not associated with any specific blood group (P = 0.951). No notable difference was found between patients with CD with or without gluten-free diet compliance in terms of the distribution of ABO blood groups and Rhesus (Rh) factor. Therefore, it can be inferred that all blood groups and subgroups carry an equal risk for CD.

Exploring galectin interactions with human milk oligosaccharides and blood group antigens identifies BGA6 as a functional galectin-4 ligand

Galectins (Gals), a family of multifunctional glycan-binding proteins, have been traditionally defined as β-galactoside binding lectins. However, certain members of this family have shown selective affinity towards specific glycan structures including human milk oligosaccharides (HMOs) and blood group antigens. In this work, we explored the affinity of human galectins (particularly Gal-1, -3, -4, -7 and -12) towards a panel of oligosaccharides including HMOs and blood group antigens using a complementary approach based on both experimental and computational techniques. While prototype Gal-1 and Gal-7 exhibited differential affinity for type I vs. type II Lac/LacNAc residues and recognized fucosylated neutral glycans, chimera-type Gal-3 showed high binding affinity towards poly-LacNAc structures including LNnH and LNnO. Notably, the tandem-repeat human Gal-12 showed preferential recognition of 3-fucosylated glycans, a unique feature among members of the galectin family. Finally, Gal-4 presented a distinctive glycan-binding activity characterized by preferential recognition of specific blood group antigens, also validated by saturation transfer difference nuclear magnetic resonance (STD-NMR) experiments. Particularly, we identified oligosaccharide blood group A type 6 (BGA6) as a biologically relevant Gal-4 ligand, which specifically inhibited IL-6 secretion induced by this lectin on human peripheral blood mononuclear cells. These findings highlight unique determinants underlying specific recognition of HMOs and blood group antigens by human galectins, emphasizing the biological relevance of Gal-4-BGA6 interactions, with critical implications in the development and regulation of inflammatory responses.

Associations of air pollution with acute coronary syndromes based on A/B/AB versus O blood types: case-crossover study

Short-term exposure to air pollutants may contribute to an increased risk of acute coronary syndrome (ACS). This study assessed the role of short-term exposure to fine particulate matter (PM2.5) as well as fine and coarse PM (PM10) air pollution in ACS events and the effect of blood groups on this phenomenon. A retrospectively collected database of 9026 patients was evaluated. The study design was a case-crossover using a conditional logistic regression model. The main analysis focused on PM2.5 levels with a 1 day lag until the ACS event, using threshold-modelled predictor for all patients. Secondary analyses utilized separate threshold-modelled predictors for 2–7-days moving averages and for patients from specific ABO blood groups. Additional analysis was performed with the non-threshold models and for PM10 levels. Short-term exposure to increased PM2.5 and PM10 levels at a 1-day lag was associated with elevated risks of ACS (PM2.5: OR = 1.012 per + 10 µg/m3, 95% CI 1.003, 1.021; PM10: OR = 1.014 per + 10 µg/m3, CI 1.002, 1.025) for all patients. Analysis showed that exposure to PM2.5 was associated with increased risk of ACS at a 1-day lag for the A, B or AB group (OR = 1.012 per + 10 µg/m3, CI 1.001, 1.024), but not O group (OR = 1.011 per + 10 µg/m3, CI 0.994, 1.029). Additional analysis showed positive associations between exposure to PM10 and risk of ACS, with 7-days moving average models stratified by blood group revealing that exposures to PM2.5 and PM10 were associated with elevated risk of ACS for patients with group O. Short-term exposures to PM2.5 and PM10 were associated with elevated risk of ACS. Short-term exposure to PM2.5 was positively associated with the risk of ACS for patients with A, B, or AB blood groups for a 1-day lag, while risk in O group was delayed to 7 days.

Homologous blood transfusion and doping: Where are we now?

Homologous blood transfusion (HBT) is used for doping in endurance sports since the 1960s. The blood comes from a compatible donor, that is, someone with a compatible ABO and rhesus blood group. Despite been prohibited by the IOC in 1985, no detection method was available until 2003. Then came the idea to use red blood cells (RBC) minor blood groups antigens that constitute an "identity" card of someone's RBC to detect the presence of a second RBC population. The method validated for doping control samples uses flow cytometry after incubation of isolated RBC with eight to 12 primary antibodies against specific minor blood groups antigens. The presence of double populations of RBC is revealed by a major and a minor peak in a fluorescence histogram. The sensitivity was estimated sufficient to detect HBT for a few weeks. Despite the complexity and cost of the method, right after its application in 2004, several cases of HBT were identified but the number of cases dropped rapidly over the years. In the 2010s, other ways to detect HBT were developed and evaluated: indirect detection using the Athlete Biological Passport approach, and a few years later forensic DNA analysis to establish the presence of two different DNA in a blood sample after HBT. Despite the high specificity of the latter, the sensitivity was recently questioned in vivo. Nowadays, the flow cytometry method remains the method of choice for HBT detection and recent investigations helped to simplify the method and increase its specificity and sensitivity.

To Determine the Blood Group Correlation among the Cases of Dysvascular Amputation: Retrospective Study

Abstract Objective: The objective of the study was to identify the association of specific blood group among the cases of dysvascular amputation. Introduction: Literature showed the association of certain blood group with increased cardiovascular risk and other thrombotic vascular diseases in addition to increased gastric cancer risk and periodontal disease. By the way of extending the relation between blood group and atherosclerosis, this study aims to find out if there is any correlation between blood group and dysvascular amputation. Materials and Methods: Retrospective analysis of patient records with sample size of 100 is considered for this study. Sample population included was patients with lower limb amputation due to dysvascular etiology, who were admitted for prosthesis for a period of 1 year at Government Institute of Rehabilitation Medicine. Statistical analysis was performed using the standard statistical software. Results: Analysis showed that there is a correlation between non-O blood group and dysvascular amputation compared to O group. Among non-O group, population with B +ve has higher incidence of amputation as analysed from the study. Conclusion: This study reveals that there is a strong correlation between dysvascular amputation and non-O blood group. Focus on the prevention of modifiable risk factors may reduce the incidence of amputation for risk-prone blood group.

A Retrospective Study on Smell Dysfunction in COVID-19 Patients Presenting to a Tertiary Care Teaching Hospital in Northern India

Introduction: The smell dysfunction in COVID-19 patients has remained an unexplained topic. The blood parameters’ variability in COVID-19 patients with anosmia has been studied in few literatures. The study is aimed to find the association of anosmia with the blood grouping and C-reactive protein (CRP) levels in coronavirus-infected patients. Materials and Methods: Database from Medical Records Department of a Tertiary Care Teaching Hospital in Northern India was searched from July 2020 to December 2020. Every fifth file was selected using the stratified random sampling. Laboratory-confirmed COVID-19 cases by reverse transcription-polymerase chain reaction files were included. Blood grouping and CRP levels were assessed and statistically correlated. Results: A total of 103 patients of coronavirus-associated infection with anosmia were included among which 52 (50.48%) patients were from moderate category of AIIMS-ICMR joint task Force’s clinical guidelines. A total of 44 (42.71%) patients had moderate levels of elevated CRP. The blood Group B-type was found most commonly in 35 (33.98%) patients. The correlation of severity of COVID-19 infection with CRP was found to be statistically significant (Chi-square test statistic was 31.203 and P = 0.00023) in patients presenting with smell dysfunction. Conclusion: Anosmia was found to a suggestive symptom for the early identification of coronavirus-infected cases. In this study, CRP levels showed statistically significant association with anosmia in COVID-19 patients. Predilection for specific blood groups serves as platform for further research.

EFFECT OF LECTINS FROM SELECTED MALAYSIAN LOCAL FRUITS ON HUMAN BLOOD GROUP ANTIGENS

Many individuals nowadays enjoy eating various types of local fruits without realising the impact of the fruits on blood group antigens. The fruit lectin can cause damage to the mucosal surface in the gut when the lectin is incompatible with blood group antigens. Therefore, the present study aims to determine the in vitro plant lectins reaction from the extraction of Artocarpus heterophyllus Lam. (Jackfruit), Artocarpus altilis (Parkinson ex F.A.Zorn), Fosberg (Breadfruit), Carica papaya (Papaya), Manilkara zapota (L.) P. Royen (Sapota) and Salacca zalacca (Gaertn.) Voss (Salak) with specific human blood group antigens. The local fruit extract was tested with human blood groups A and B for hemagglutination assay. The agglutination titer of the hemagglutination assay results was then evaluated. The total of 3+ reactions for jackfruit was 11%, salak (4%) and papaya(6%) for both blood groups. The breadfruit shows the highest titer reaction, 19% against A and 16% against B. In comparison, 19% was against A for sapota but only 4% towards group B. The highest titer value of erythrocytes by crude lectins of selected local fruits on blood groups A and B was given by extraction of sapota while for blood group B on papaya. This discovery proves that plant lectins from five varieties of local fruits react with blood group antigens and that comparable interactions may occur at the mucosal surface of the gut in susceptible individuals, causing significant inflammation, swelling, and ulceration. The mechanism and effect of fruit lectin on human blood types should be investigated further.

Blood group A enhances SARS-CoV-2 infection

AbstractAmong the risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ABO(H) blood group antigens are among the most recognized predictors of infection. However, the mechanisms by which ABO(H) antigens influence susceptibility to COVID-19 remain incompletely understood. The receptor-binding domain (RBD) of SARS-CoV-2, which facilitates host cell engagement, bears significant similarity to galectins, an ancient family of carbohydrate-binding proteins. Because ABO(H) blood group antigens are carbohydrates, we compared the glycan-binding specificity of SARS-CoV-2 RBD with that of galectins. Similar to the binding profile of several galectins, the RBDs of SARS-CoV-2, including Delta and Omicron variants, exhibited specificity for blood group A. Not only did each RBD recognize blood group A in a glycan array format, but each SARS-CoV-2 virus also displayed a preferential ability to infect blood group A–expressing cells. Preincubation of blood group A cells with a blood group-binding galectin specifically inhibited the blood group A enhancement of SARS-CoV-2 infection, whereas similar incubation with a galectin that does not recognize blood group antigens failed to impact SARS-CoV-2 infection. These results demonstrated that SARS-CoV-2 can engage blood group A, providing a direct link between ABO(H) blood group expression and SARS-CoV-2 infection.

A Research Paper on Blood Donation Management System (Donor Dreams)

bstract: Blood donation is a critical aspect of healthcare that saves millions of lives every year. However, findingthe right blood donor or blood bank in times of emergencies can be a challenging task, leading to severe consequences, including death. Traditional methods of finding blood donors and blood banks are time-consuming and fragmented, making it difficult for patients to access the required blood units. To address this issue, we propose a web application called "Donor Dreams," which connects blood banks and patients on a single platform. The system maintains a record of every blood bank to keep track of theblood stock and simplifies the search for available blood donors or blood banks. The proposed system consists of three modules: Admin, Blood Bank, and Patient. The Admin module provides realtime data on available blood units and blood banks, updates the blood bank and patient details, and approves or rejects requests made by blood banks and patients. The Blood Bank module allows blood banks to createan account, view their donation history and request for blood from the blood stock. The Patient module enables patients to create an account, request for specific blood groups, and view their blood request history. Our research aims to provide a user-friendly and centralized platform that can connect blood banks and patients in real-time, ultimately saving more lives and making a positive impact on society.

Ultrasonic testing of the biomechanical properties of donation blood

Background. Donated blood is routinely preserved for about six weeks. After that, a considerable amount of unused blood is discarded for safety. We carried out sequential measurements of the ultrasonic parameters (Velocity of propagation of ultrasound, its attenuation, and relative nonlinearity coefficient B/A) for red blood cells (RBCs) bags in their physiological preserving conditions in the blood bank, in a given experimental setup, to investigate the gradual deteriorations in the biomechanical properties of RBCs. Materials and Methods. We discuss our primary findings, which indicate the applicability of ultrasound techniques as a quantitative quick, non-invasive routine check for the validity of sealed blood bags. The technique can be applied during and beyond the regular preservation period, thus enabling deciding for each bag to either further preserve or withdraw. Results and Discussion. Considerable increases in the velocity of propagation (ΔV = 966 m s−1) and ultrasound attenuation (Δα = 0.81 dB C−1m−1) were detected to take place during the preservation time. Likewise, the relative nonlinearity coefficient showed a generally rising trend during the preservation period (Δ(B/A) = 0.0129). At the same time, a distinctive feature characteristic of a specific blood group type is realized in all cases. Due to the complex stress-strain relations and their reflection on the hydrodynamics and flow rate of non-Newtonian fluids, the increased viscosity of long-preserved blood may justify the known post-transfusion flow complications.

ABO Blood Group and Associated Coronavirus Disease (COVID-19)

Coronavirus disease (COVID-19) or (SARS-CoV-2) is a pandemic disease represents a public health crisis that causes actual morbidity and mortality. The disease characterized by respiratory infection and spread worldwide after an outbreak initiated in Wuhan, China, in December 2019. The novel coronavirus disease has been spreading around the world rapidly and declared as a pandemic by WHO. Our aim in this meta-analysis of many different studies to find out the susceptibility of infection by COVID-19 and individuals having specific ABO blood group. This systematic review and meta-analysis covered most of the comparison of many studies carried out since Marsh 2019 up to May 2021, and indicated that blood group A and B was associated with an increased risk of infection (susceptibility) or death (severity), whereas blood group O appears to be protective and associated with a decreased risk of infection or death. Keywords: COVID-19, SARS-CoV-2, ABO blood group, disease susceptibility

Association of blood group with COVID-19 disease susceptibility and severity in Saudi Arabia.

Novel SARS-CoV-2 (COVID-19) virus has rapidly spread worldwide and was declared a pandemic, making identifying and prioritizing individuals most at risk a critical challenge. The literature describes an association between blood groups and the susceptibility to various viral infections and their severity. Knowing if a specific blood group has more susceptibility to COVID-19 may help improve understanding the pathogenesis and severity of the disease. We aimed to assess the association between ABO/RhD and COVID-19 susceptibility and severity, and to compare results with similar studies in Saudi Arabia. This study was conducted between March and October 2021 on 600 patients confirmed positive for COVID-19 infection. Patients' data were collected and analyzed. As a control, 8423 healthy blood donors were enrolled as a sample representative of the population for blood group distribution. More individuals had blood group B in the COVID-19 group in comparison with the control group (24.2% vs. 18%), The opposite was observed among individuals of group O (39.5% vs. 47.3%). The B blood group was predictive of higher risk of mortality. No significant difference in the distribution of RhD was observed between the COVID-19 and the control groups. Neither ABO nor RhD was significantly associated with the severity of COVID-19. Although there was no significant association with the disease severity, the B blood group may be associated with a higher risk for COVID-19 infection. Further studies with a larger sample size are necessary to evaluate this correlation.

Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype

Blood phenotypes are defined by the presence or absence of specific blood group antigens at the red blood cell (RBC) surface, due to genetic polymorphisms among individuals. The recent development of genomic and proteomic approaches enabled the characterization of several enigmatic antigens. The choline transporter‐like protein CTL2 encoded by the SLC44A2 gene plays an important role in platelet aggregation and neutrophil activation. By investigating alloantibodies to a high‐prevalence antigen of unknown specificity, found in patients with a rare blood type, we showed that SLC44A2 is also expressed in RBCs and carries a new blood group system. Furthermore, we identified three siblings homozygous for a large deletion in SLC44A2, resulting in complete SLC44A2 deficiency. Interestingly, the first‐ever reported SLC44A2‐deficient individuals suffer from progressive hearing impairment, recurrent arterial aneurysms, and epilepsy. Furthermore, SLC44A2null individuals showed no significant platelet aggregation changes and do not suffer from any apparent hematological disorders. Overall, our findings confirm the function of SLC44A2 in hearing preservation and provide new insights into the possible role of this protein in maintaining cerebrovascular homeostasis.

Resolving discrepancies in forward and reverse ABO blood group typing

Background/Aim: There is a need of investigation of high frequency of the cases of ABO discrepancy revealed by forward and reverse typing. The aim of the study was to reveal optimal methods for detection of weak subgroups of group A and B antigens on erythrocytes. Methods: Sixteen persons with A blood group and anti-B antibody adsorbing ability (weak Bel, Bm and B3 antigens), 5 persons with B blood group and anti-A antibody adsorbing ability (weak Ax antigen) and 2 persons with O blood group and anti-B antibody adsorbing ability (weak Bel antigen) were investigated as the cases of type II-III of ABO discrepancy and weak B antigen. Liquid chromatography, agglutination, inhibition of agglutination and adsorption reactions at 4 °C and 37 °C with prolonged incubation (12 hours) were used in the study. Results: The persons with A blood group revealed by forward typing at 4 °C and O blood group detected by reverse typing at 37 °C showed the ability of the erythrocytes to adsorb anti-B antibody. The persons with B blood group revealed by forward typing with presence of anti-B antibodies reactive at 37 °C showed the ability of erythrocytes to adsorb anti-A antibody. Prolonged incubation at reverse typing, adsorption-elution tests, inhibition of haemagglutination and liquid chromatography were used to define blood group specificity. Conclusion: Prolonged incubation during reverse typing at 4 °C and 37 °C, adsorption at 4 °C, heat elution and liquid chromatography might help to detect blood group type in cases of type II-III of ABO discrepancy.

PROBABILITY OF COVID-19 IN ABO BLOOD TYPE DURING SECOND WAVE IN SOUTHERN RAJASTHAN, INDIA

Objectives: Along the course human history of scientific research, the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is the most concerning global health problem. Second wave of COVID-19 has adversely affected India. However, India embarked on its immunization program on January 16, 2021, operating 3006 vaccination centers onset Covaxin and CoviShield. This study aimed to ascertain if there is an association amidst ABO blood type and probability of COVID-19 infection in wave. Methods: This is analytical and observational study conducted on 713 SARS-COVID-19-positive patients of a known ABO blood type, who attended outpatient department and inpatient department during March 26–May 20, 2021, in tertiary care hospital Udaipur (Raj.) Serum inflammatory markers were evaluated by Cobas 6000. Results: Out of the 713 patients who were tested positive, 15.56% was blood group Type A, 19.91% was blood group Type B, 13.65% was blood group Type AB, and 46.28% was blood group Type O. On statistical analysis, there were positive association between O+ blood type and peak inflammatory marker (interleukin-6 and D-Dimer). Patients with blood Type O who received a test were more likely to test positive and blood Type B+, A+, A+,AB+,O-,A-,B-, and AB- were less likely to test positive. Conclusion: The present study shows an evidence for interrelation between ABO blood groups and SARS-COVID-19. Reported infection prevalence is moderately increased among O+ blood type individuals. Determination of level of inflammatory markers might prove to be helpful to clinicians so as to keep track of severity of infection and evaluate the prognosis of SARS-COVID-19 with specific ABO blood groups.

Association of Different ABO and Rh Blood Groups with the Erythroprotective Effect of Extracts from Navicula incerta and Their Anti-Inflammatory and Antiproliferative Properties.

Previous studies have reported that different blood groups are associated with the risk of chronic degenerative diseases that mainly involve inflammation and neoplastic processes. We investigate the relationship between blood groups and the erythroprotective effect of extracts from Navicula incerta against oxidative damage as a proposal to develop drugs designed for people with a specific blood type related to chronic pathology. The study was carried out through the elucidation of the erythroprotective potential, anti-inflammatory and antiproliferative activity of Navicula incerta. Research suggests that the presence or absence of certain blood groups increases or decreases the abilities of certain phytochemicals to inhibit oxidative stress, which is related to the systemic inflammatory response involved in the development of different types of cancer. The pigment-rich extracts from Navicula incerta inhibit ROO•- induced oxidative stress in human erythrocytes on the A RhD+ve antigen without compromising the structure of the cell membrane. This result is very important, since the A antigen is related to the susceptibility of contracting prostate cancer. Similarly, it was possible to inhibit the proliferation of cervical (HeLa) and prostate (PC-3) carcinoma. The combinatorial analysis of different biological activities can help design phytochemicals as new candidates for preventive drugs treating the chronic degenerative diseases associated with a specific blood group.

Immunological Compatibility of Novel Enzyme-Converted Universal Blood Donor Cells

Introduction: In transfusion, unintentional mismatching of blood groups remains one of the most common causes of serious and sometimes fatal adverse reactions. Scarcity of certain blood types is another major transfusion challenge. The ABO blood group specificity is determined by the terminal monosaccharides, N-acetylgalactosamine on A and galactose on B RBCs. To create a universal blood supply, cell surface engineering has been studied as a method to minimize the immunological rejection of donor cells. Enzymatic removal of immunodominant sugars would uncover universally acceptable H-antigen (O group RBC). However, enzymatic conversion of A-type RBCs was lagging due to a lack of very active and specific glycosidases and the complex nature of the A blood group antigen. In this research, the performance of two novel enzymes that act together extremely efficiently to convert A-type RBCs to universal donor O RBCs, with high specificity for A antigen, is evaluated. Optimal conversion conditions are explored, as well as the immunological compatibility of the converted RBCs. Materials & Methods: Whole blood samples are collected from consenting A donors (with approval from the University of British Columbia clinical research ethics board), washed and diluted to 10 % hematocrit in PBS buffer (pH7.4). The washed RBCs were treated with the newly developed glycosidases for 1 h at 37 oC. The efficiency of the newly developed glycosidases and the characterization of enzyme converted O (ECO)-RBCs were evaluated by gel-column based micro typing system (MTS) cards against A antigen and flow cytometry using anti A and H antibodies. Safety and compatibility of ECO-RBCs were assessed by blood group serology studies. In brief, ECO-RBCs were incubated in Rh-matched sera collected from diverse donors and any serum reactivity against ECO-RBCs was assessed using anti IgG MTS cards and flow cytometry using anti C3d (complement protein) antibody. To further confirm the cross-matching of ECO-RBCs, the monocyte monolayer assay (MMA), a clinically used method, was performed using monocytes collected from B and O blood donors to assess the phagocytic activity against ECO-RBCs pre-incubated with serum samples. Phagocytic activity against ECO-RBCs was calculated using the monocyte index (MI). Results: Anti A MTS cards and flow cytometry analysis of antigen A and H expression, after enzymatic treatment, confirmed successful conversion of A blood group to universal O group. Our studies showed no significant hemolysis and no complement protein (C3d) deposition on ECO-RBCs pre-incubated with diverse sera, demonstrating the compatibility. Serology studies showed that ECO-RBCs are compatible with most sera (~50 donors) studied under transfusion conditions, though serum reactivity was shown by some O and B sera. A MI value of ≤ 6 % was obtained for all ECO-RBCs indicating minimal risk of an acute hemolytic reaction associated with ECO-RBC transfusion. Conclusions: We have developed novel glycosidases that efficiently remove immunodominant A antigen from RBC surfaces with high specificity to create universal blood donor cells at neutral pH and at enzyme concentrations that are much lower than those previously required. Based on preliminary results, ECO-RBCs have the potential to increase donor blood supply and thereby greatly advance the field of transfusion.

Diagnostic Accuracy of Absorption Elution Assay to Detect Specific Blood Group Antigens in Saliva of Children

Diagnostic Accuracy of Absorption Elution Assay to Detect Specific Blood Group Antigens in Saliva of Children

PROTHROMBIN COMPLEX CONCENTRATE IN EMERGENCY DEPARTMENT.

SUMMARYCoagulation abnormalities are common in bleeding or critically ill patient and hemostatic management remains a major challenge for the emergency physician. Management of bleeding patients consists of bleeding control, restoration of blood volume, and correction of any associated coagulopathy. Traditionally, the fresh frozen plasma (FFP) is used for correction of coagulopathy to manage and prevent bleeding, but today Prothrombin complex concentrates (PCCs) offer an attractive alternative because they offers a number of advantages over FFP, including lower infusion volume, rapid INR normalization, faster availability, lack of blood group specificity, and better safety profile. The aim of the present review is to provide an short overview about using PCC, their indication, efficacy and safety in different bleeding setting’s.

Prevalence of color vision deficiency and it’s relation with ABO blood group among medical students

Background: Normal human beings can appreciate color in all three of it’s attributes; Hue, intensity, and saturation. Human beings can perceive three primary colors, that is, red, green, and blue. Any defect in appreciation of colors is known as color vision deficiency (CVD). Complete inability to appreciate color is known as color blindness. The genes for red and green cone pigments are found in the q arm of the X chromosome. Hence, red and green CVD are inherited as X-linked recessive diseases. Blue CVD is autosomaly inherited. Blood groups are genetically inherited as well. Although it is a known fact that there is a preponderance of genetic diseases in subjects belonging to a specific blood group, no such study was available in Western Odisha as per our knowledge. This becomes more relevant as consanguineous marriages are a serious social problem in that part of Odisha. Aim and Objectives: Therefore, the study was undertaken to find out the prevalence of CVD among Medical students in Western Odisha and to find out it’s relation, if any, with ABO blood groups, as these two entities are genetically inherited. Record should be kept for future use, especially for counseling at the time of marriage and if necessary, to choose a subject for further study, where color detection does not play an important part. Materials and Methods: Prior permission was taken from the Institutional Ethics Committee to carry out this study. The study was carried out among the 1st–4th year medical students of V.S.S. Medical College and Hospital (n = 690) from August 2022 to October 2022. Ishihara test plates for color vision and agglutination method for ABO blood grouping were employed to get the prevalence of CVD and to get the percentage of subjects belonging to each blood group among those having CVD. The observations were noted carefully. Results: After careful screening, it was seen that 647 (93.76%) were normal, 42 (6.08%) had CVD, and 1 (0.14%) subject was completely color blind. All those affected were males. Distribution of blood group in CVD subjects showed 7 (16.27%) numbers belonging to blood group A, 22 (51.16%) belonging to blood group B, 1 (2.3%) belonging to blood group AB, and 12 (27.9%) belonging to blood group O. The only color blind student belonged to blood group B (2.3%). Conclusion: As medical students have to deal with colors throughout their career, the study helps the subjects to be aware of their condition early in their professional life. It also tried to find out the percentage distribution into ABO blood groups. A larger population should be included to get more accurate results.